Key result
Elevated IGF1 linked to ~3.7-fold higher odds of plaque erosion in STEMI.
Why the study?
Plaque erosion and plaque rupture have different characteristics and treatment needs in STEMI, but few non-invasive plasma biomarkers exist to distinguish them.
Can plasma proteomics profiling identify non-invasive biomarkers to distinguish plaque erosion from plaque rupture in STEMI patients?
Observational (n=108)
No
Can plasma proteomics profiling identify non-invasive biomarkers to distinguish plaque erosion from plaque rupture in STEMI patients?
IGF1, COL6A2, and FERMT3 are potential non-invasive plasma biomarkers for identifying plaque erosion in STEMI patients.
Answers are grounded in this paper and cite their sources.
May aid non-invasive identification of plaque erosion in STEMI; hypothesis-generating and requires prospective validation before clinical use.
BACKGROUND: Plaque erosion (PE) has been considered a secondary pathogenesis of ST-segment elevated myocardial infarction (STEMI) following plaque rupture (PR). Previous studies demonstrated that they had different demographic and histology characteristics and need different treatment strategy. But there are few non-invasive plasma biomarkers for distinguishing them. The present study aimed to identify non-invasive predictive biomarkers for PE and PR in patients with STEMI. METHODS AND RESULTS: A total 108 patients were recruited and grouped into a PE group (n=36), a PR group (n=36), and an unstable angina pectoris (UAP) (n=36) group for analysis. A 9-plex tandem mass tag (TMT)-based proteomics was used to compare plasma protein profiles of PE, PR, and UAP. In total, 36 significant differential proteins (DPs) were identified among groups, 10 of which were screened out using bio-information analysis and validated with enzyme-linked immunosorbent assay (ELISA). The relationship of angiography and optical coherence tomography (OCT) imaging data and the 10 target DPs was analyzed statistically. Logistic regression showed elevated collagen type VI α-2 chain (COL6A2) and insulin-like growth factor 1 (IGF1), and decreased fermitin family homolog 3 (FERMT3), were positively associated with PE. Multivariate analysis indicated IGF1, FERMT3, and COL6A2 had independent predictive ability for PE. IGF1 was inversely correlated with lumen stenosis and the lipid arc of the plaque. CONCLUSIONS: IGF1, COL6A2, and FERMT3 are potential predictive biomarkers of PE in STEMI patients. And IGF1 was negatively correlated with the developing of culprit plaque.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) conducted an observational in ST-Segment Elevated Myocardial Infarction (STEMI) and Unstable Angina Pectoris (UAP) (n=108). Plasma biomarkers (IGF1, FERMT3, COL6A2) vs. Plaque rupture and unstable angina pectoris was evaluated on Association of continuous IGF1 expression (Z score) with plaque erosion (OR 3.68, 95% CI 1.55-8.72, p=0.003). Elevated plasma levels of insulin-like growth factor 1 and collagen type VI α-2 chain, and decreased fermitin family homolog 3, were independently associated with plaque erosion in STEMI.
Synapse has enriched 10 related papers. Consider them for comparative context: